BIOCON PHARMA INC 2023-02-15 Health serious FDA
Health · FDA · Recall #FDA-D-0268-2023
Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for:… Recall
Issued February 15, 2023 · BIOCON PHARMA INC
In February 2023, BIOCON PHARMA INC recalled the Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for:…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
What you should do
- 1 Stop using Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact BIOCON PHARMA INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- BIOCON PHARMA INC
- Category
- Health
- Recall date
- February 15, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0268-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- BIOCON PHARMA INC has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.